-
Je něco špatně v tomto záznamu ?
Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein
Vlasáková J, Nováková Z, Rossmeislová L, Kahle M, Hozák P, Hodny Z.
Jazyk angličtina Země Spojené státy americké
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- aktivace transkripce účinky léků MeSH
- financování organizované MeSH
- histondeacetylasy MeSH
- inhibitory enzymů farmakologie MeSH
- inhibitory histondeacetylas MeSH
- interferon alfa farmakologie MeSH
- jaderné proteiny genetika MeSH
- kultivované buňky MeSH
- lidé MeSH
- nádorové buňky kultivované MeSH
- nádorové proteiny genetika MeSH
- nádorové supresorové proteiny genetika MeSH
- RNA nádorová analýza MeSH
- transkripční faktor STAT2 metabolismus MeSH
- transkripční faktory genetika MeSH
- upregulace účinky léků MeSH
- Check Tag
- lidé MeSH
Department of Cell Ultrastructure and Molecular Biology, Institute of Experimental Medicine, Promyelocytic leukemia nuclear bodies (PML NBs), the structural domains of the eukaryotic cell nucleus, play a role in cancer and apoptosis, and their involvement in antiviral mechanisms mediated by interferons (IFNs) is proposed. IFNs dramatically increase the transcription of the PML gene. In this study, we have shown that the response of 2 structural PML NB components, PML and Sp100, to interferon-alpha (IFNalpha) was suppressed in cells simultaneously treated with histone deacetylase (HDAC) inhibitors (trichostatin A, sodium butyrate, MS-275, SAHA, and valproic acid). Trichostatin A (TSA) blocked the increase of PML NB number and suppressed up-regulation of PML mRNA and protein levels in several human cell lines and in normal diploid skin fibroblasts. Moreover, IFNalpha induction of IRF-1 was also inhibited by TSA, although incompletely. Promyelocytic leukemia nuclear bodies (PML NBs), the structural domains of the eukaryotic cell nucleus, play a role in cancer and apoptosis, and their involvement in antiviral mechanisms mediated by interferons (IFNs) is proposed. IFNs dramatically increase the transcription of the PML gene. In this study, we have shown that the response of 2 structural PML NB components, PML and Sp100, to interferon-alpha (IFNalpha) was suppressed in cells simultaneously treated with histone deacetylase (HDAC) inhibitors (trichostatin A, sodium butyrate, MS-275, SAHA, and valproic acid). Trichostatin A (TSA) blocked the increase of PML NB number and suppressed up-regulation of PML mRNA and protein levels in several human cell lines and in normal diploid skin fibroblasts. Moreover, IFNalpha induction of IRF-1 was also inhibited by TSA, although incompletely.
Citace poskytuje Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc09003752
- 003
- CZ-PrNML
- 005
- 20111210153100.0
- 008
- 091124s2007 xxu e eng||
- 009
- AR
- 024 __
- $a 10.1182/blood-2006-02-003418 $2 doi
- 035 __
- $a (PubMed)17062732
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vlasáková, Jana. $7 _AN040745
- 245 10
- $a Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein / $c Vlasáková J, Nováková Z, Rossmeislová L, Kahle M, Hozák P, Hodny Z.
- 314 __
- $a Department of Cell Ultrastructure and Molecular Biology, Institute of Experimental Medicine, Department of Biology of the Cell Nucleus, Institute of Molecular Genetics [corrected] Academy Sciences of the Czech Republic, Prague, Czech Republic
- 520 9_
- $a Department of Cell Ultrastructure and Molecular Biology, Institute of Experimental Medicine, Promyelocytic leukemia nuclear bodies (PML NBs), the structural domains of the eukaryotic cell nucleus, play a role in cancer and apoptosis, and their involvement in antiviral mechanisms mediated by interferons (IFNs) is proposed. IFNs dramatically increase the transcription of the PML gene. In this study, we have shown that the response of 2 structural PML NB components, PML and Sp100, to interferon-alpha (IFNalpha) was suppressed in cells simultaneously treated with histone deacetylase (HDAC) inhibitors (trichostatin A, sodium butyrate, MS-275, SAHA, and valproic acid). Trichostatin A (TSA) blocked the increase of PML NB number and suppressed up-regulation of PML mRNA and protein levels in several human cell lines and in normal diploid skin fibroblasts. Moreover, IFNalpha induction of IRF-1 was also inhibited by TSA, although incompletely. Promyelocytic leukemia nuclear bodies (PML NBs), the structural domains of the eukaryotic cell nucleus, play a role in cancer and apoptosis, and their involvement in antiviral mechanisms mediated by interferons (IFNs) is proposed. IFNs dramatically increase the transcription of the PML gene. In this study, we have shown that the response of 2 structural PML NB components, PML and Sp100, to interferon-alpha (IFNalpha) was suppressed in cells simultaneously treated with histone deacetylase (HDAC) inhibitors (trichostatin A, sodium butyrate, MS-275, SAHA, and valproic acid). Trichostatin A (TSA) blocked the increase of PML NB number and suppressed up-regulation of PML mRNA and protein levels in several human cell lines and in normal diploid skin fibroblasts. Moreover, IFNalpha induction of IRF-1 was also inhibited by TSA, although incompletely.
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a histondeacetylasy $7 D006655
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interferon alfa $x farmakologie $7 D016898
- 650 _2
- $a nádorové proteiny $x genetika $7 D009363
- 650 _2
- $a jaderné proteiny $x genetika $7 D009687
- 650 _2
- $a RNA nádorová $x analýza $7 D012334
- 650 _2
- $a transkripční faktor STAT2 $x metabolismus $7 D050795
- 650 _2
- $a transkripční faktory $x genetika $7 D014157
- 650 _2
- $a aktivace transkripce $x účinky léků $7 D015533
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 650 _2
- $a nádorové supresorové proteiny $x genetika $7 D025521
- 650 _2
- $a upregulace $x účinky léků $7 D015854
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a inhibitory histondeacetylas $7 D056572
- 700 1_
- $a Nováková, Zora. $7 _AN031782
- 700 1_
- $a Rossmeislová, Lenka $7 xx0095550
- 700 1_
- $a Kahle, Michal $7 xx0085329
- 700 1_
- $a Hozák, Pavel, $d 1958- $7 js20040517003
- 700 1_
- $a Hodný, Zdeněk $7 xx0074117
- 773 0_
- $w MED00000807 $t Blood $g Roč. 109, č. 4 (2007), s. 1373-1380 $x 0006-4971
- 910 __
- $a ABA008 $b B 405 $y 8
- 990 __
- $a 20091123115031 $b ABA008
- 991 __
- $a 20091124172204 $b ABA008
- 999 __
- $a ok $b bmc $g 696563 $s 558922
- BAS __
- $a 3
- BMC __
- $a 2007 $b 109 $c 4 $d 1373-1380 $i 0006-4971 $m Blood $x MED00000807
- LZP __
- $a 2009-B3/dkme